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Acute rheumatic fever (ARF), with its varied and 
potentially devas tating cardiac complication of 
rheumatic heart disease (RHD), has largely been 
eradicated from developing countries, but continues 
to be a scourge mainly in poorly resourced areas 
of the world and also among the indigenous populations of some 
wealthy countries such as New Zealand and Australia.[1] The disease 
is particularly prevalent in populations where there is overcrowding 
and high levels of poverty. Efforts have been made to commit 
to the elimination of ARF/RHD in South Africa (SA) and the 
rest of Africa. The Drakensberg Declaration, which initiated and 
promoted the Awareness, Surveillance, Advocacy and Prevention 
(ASAP) programme to raise public awareness, establish surveillance 
programmes, advocate for support and promote prevention, was 
adopted at the 1st All Africa Workshop on Rheumatic Fever and 
Rheumatic Heart Disease held in the Drakensberg, SA, in 2005.[2] 
The ASAP programme has unfortunately not been expanded on a 
national scale so far. Subsequent attempts at solutions to controlling 
ARF and RHD globally have included the establishment of registers 
to track disease outcomes and outline strategies related to the ASAP 
proposal to improve disease control in low-income countries.[3]
Information about levels of ARF/RHD is scarce and poorly 
documented in less-developed areas of the world such as Africa.[4] 
The prevalence of RHD in SA has been reported occasionally since 
the landmark study by McClaren et al.[5] in 1975, which showed 
an overall prevalence rate of RHD (using clinical examination to 
establish the diagnosis) of 6 - 9/1 000 among schoolchildren in 
Soweto, Johannesburg. A prospective clinical registry of valvular 
heart disease using echocardiography to make the diagnosis during 
2006/2007 among individuals older than 14 years at Chris Hani 
Baragwanath Academic Hospital in Soweto revealed an incidence 
of 23.5/100 000 patients with RHD presenting for the first time.[6] 
Recent information from the past decade concerning the prevalence 
of RHD in sub-Saharan Africa has emanated from echocardiography 
screening studies in asymptomatic schoolchildren. Marijon et al.[7] 
showed a very high prevalence rate of 30.4/1 000 in Mozambique in 
2007. A similarly high prevalence rate of 15/1 000 in a much larger 
cohort of Ugandan schoolchildren was reported in 2012.[8] Two very 
recent cardiac clinic hospital-based study cohorts from Africa, using 
echocardiography to confirm diagnoses, showed RHD to be the most 
important heart condition in patients aged 10 - 19 years (affecting 
62.1%) in Cameroon,[9] while RHD was present in 22.4% of children 
undergoing echocardiography at a centre in Malawi.[10]
In contrast, a recent publication from SA[11] has shown a dramatic 
decline in the number of children younger than 14 years with ARF 
and RHD presenting to the paediatric cardiology department at Chris 
Hani Baragwanath Academic Hospital over the 17-year period 1993 - 
2010. The referral population has not changed despite an increase in 
the number of patients referred to the unit during this period. The 
population served by this large tertiary care hospital is largely poor 
and includes the massive periurban population of Soweto, patients 
referred by secondary hospitals in southern and eastern Gauteng 
Province, and patients from North West Province. The majority of 
patients with ARF/RHD were found to have originated from outside 
Soweto, but the addresses provided could not be validated. Many 
patients who present with severe disease requiring surgery to repair 
or replace damaged heart valves are suspected to originate from rural 
areas, and they include people from beyond SA’s borders who have 
made the informal settlements in and around Gauteng their home.[11]
A similar downward trend has been observed at a central hospital 
complex in Limpopo Province, where a decline in the prevalence of 
RHD among children up to 13 years old has also been documented. A 
record review of paediatric echocardiography reports for the period 
2001 - 2012 showed that the number of cases decreased from 36 per 
year for the first 4 years of the study to an average of 14 and six per 
year in the middle and final 4 years of the study, respectively. During 
the same time period the number of cases of congenital heart disease 
diagnosed each year remained relatively constant. This information 
suggests a decreasing prevalence of childhood RHD in Limpopo 
Province.[12]
Anecdotally, numbers of children presenting to large tertiary 
hospitals with ARF/RHD have declined in Free State Province, but 
not in KwaZulu-Natal and rural parts of the Eastern Cape (personal 
communications, Prof. Stephen Brown, Dr Ebrahim Hoosen and 
Dr Lungile Pepeta, respectively).
Several sociopolitical changes in SA could have contributed to the 
documented decline in the numbers of children with ARF/RHD in 
Gauteng and Limpopo provinces. These include an improvement in 
the socioeconomic status of the broader population since the new 
political dispensation in 1994, less overcrowding in dwellings, free 
healthcare for children under the age of 6 years, more widespread 
availability of primary healthcare facilities, and easy access to 
penicillin for the treatment of all sore throats.[12] The latter resulted in 
a dramatic decline in the incidence of ARF in Costa Rica and Cuba, 
as has been well documented.[13,14]
Information on the incidence and prevalence rates of ARF and 
RHD in SA and the rest of Africa is needed to ensure targeting of 
susceptible populations with prevention and treatment programmes. 
Research opportunities should therefore continue to be created 
to allow for a pan-African survey of the frequency and origins 
of patients with ARF/RHD presenting to the larger central and 
secondary hospitals in SA and other parts of Africa, to assess the need 
for control strategies in vulnerable areas.
Other methods of detection, such as screening for RHD with 
echocardiography in schoolchildren, are excellent ways to seek 
out affected individuals so that secondary prophylaxis can be 
instituted. Echocardiographic screening is, however, a very costly 
undertaking requiring expensive equipment, specialised expertise, 
reliable and relevant diagnostic echocardiographic criteria 
that can easily be replicated, and time spent by physicians and 
technical echocardiographic personnel away from their hospital 
commitments.
The eradication of ARF/RHD is a complex process that needs to 
be addressed at various levels. These include education of vulnerable 
communities about the disease, provision of easy access to medical 
care, and increasing the availability of free penicillin to treat group 
A streptococcal pharyngitis and for secondary prophylaxis against 
further attacks of ARF in patients with established RHD. Just 
as important is to address poverty and overcrowding, which are 
associated with high levels of ARF and RHD, as improvement in 
socioeconomic conditions has also been shown to promote the 
control of ARF.[15] Improvement of economic circumstances in 
disadvantaged communities is therefore also an important component 
of the management of ARF/RHD. Until such communities are 
economically empowered, ARF/RHD will continue to be a problem 
despite interventions to control the disease. All these interventions 
may prove to be a challenge in some parts of SA and in countries in 
the rest of Africa.
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